Dear Member,

So far under the PQS this year we have sent you the following:

    1.  Claim PQS aspirational payment - Email sent 17th October 2022

         (DEADLINE WAS 4TH NOV 2022)
    2.  PQS Gateway payment - Email sent 17th October 2022
    3.  Asthma domain work - Email sent 17th October 2022
    4.  Patient Safety report - Email sent 4th November 2022
    5.  Antimicrobial Stewardship - Email sent 7th November 2022
    6.  Domestic Abuse Prevention - Email sent 7th November 2022
    7.  Healthy Living Pharmacy - Email sent 7th November 2022
    8.  Level 3 Safeguarding Training - Email sent 14th November 2022

    9.  Sepsis Training - Email sent 21st November 2022

    10. Risk Management Training - Email sent 30th November 2022

    11. Risk Review - Email sent 12th December 2022

    12. Risk Cancer Awareness - Email sent 13th December

    13. Risk Cancer Awareness - Email sent 13th December

    14. NHS Obesity Campaign - Email sent 30th December

    15. Oral Contraceptive Service - Email sent 4th January

    16. Sodium Valproate Audit - Email sent 1st February

What’s next?

17. Palliative and end of life care action plans

WHAT DO YOU NEED TO DO

1. Update your NHS Profile Manager if you routinely hold the 16 palliative and end of life critical medicines listed below and can support local access to parenteral haloperidol. 

• Cyclizine solution for injection ampoules 50mg/1ml;
• Cyclizine tablets 50mg;
• Dexamethasone solution for injection ampoules 3.3mg/1ml;
• Dexamethasone tablets 2mg;
• Haloperidol tablets 500 mcg;
• Hyoscine butylbromide solution for injection 20mg/1ml;
• Levomepromazine solution for injection ampoules 25mg/1ml;
• Metoclopramide solution for injection ampoules 10mg/2ml;
• Midazolam solution for injection ampoules 10mg/2ml;
• Morphine sulfate oral solution 10mg/5ml;
• Morphine sulfate solution for injection ampoules 10mg/1ml;
• Morphine sulfate solution for injection ampoules 30mg/1ml;
• Oxycodone solution for injection ampoules 10mg/1ml;
• Oxycodone oral solution sugar free 5mg/5ml;
• Sodium chloride 0.9% solution for injection ampoules 10ml; and
• Water for injections 10ml.

2. You must also have an action plan in place containing details of what to do in the case where you do not have the required stock of the 16 critical medicines or parenteral haloperidol available for a patient.

The action plan must contain the following details:

• An awareness of any locally commissioned services for palliative care including any on call and delivery arrangements.
• A list of community pharmacies stocking the 16 critical medicines for palliative/end of life care in their area and noting the ability to check the Directory of Services (DoS) to find pharmacies stocking these medicines.
• Details of where parenteral haloperidol can be accessed locally, e.g. through any local commissioning arrangements; and
• Awareness of other support services that may be useful for patients/relatives/carers.

3. If your pharmacy is not a stockholder of these 16 palliative and end of life critical medicines, you do not have to do anything on your NHS profile Manager. This will be declared on MYS Portal by 31^st March 2023.